<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Bielefeld-CeBiTec_Results_Biosafety_Outlook"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><DIV style="height:100%" id="main_box"><DIV id="flag"><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Overview" style="color:#000000"><FLAG class="flag_element1" style="margin-left:70px;"><P class="flag"><FONT color="#FFFFFF">Overview</FONT></P></FLAG></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/rMFC" style="color:#000000"><FLAG class="flag_element2"><P class="flag"><FONT color="#FFFFFF">rMFC</FONT></P></FLAG></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/CO2-fixation" style="color:#000000"><FLAG class="flag_element3"><P class="flag"><FONT color="#FFFFFF">CO<SUB>2</SUB> Fixation</FONT></P></FLAG></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Isobutanol" style="color:#000000"><FLAG class="flag_element4"><P class="flag"><FONT color="#FFFFFF">Isobutanol</FONT></P></FLAG></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosafety" style="color:#000000"><FLAG class="flag_element5"><P class="flag"><FONT color="#FFFFFF">Biosafety</FONT></P></FLAG></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Modelling" style="color:#000000"><FLAG class="flag_element6"><P class="flag"><FONT color="#FFFFFF">Modeling</FONT></P></FLAG></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Parts" style="color:#000000"><FLAG class="flag_element7"><P class="flag"><FONT color="#FFFFFF">Parts</FONT></P></FLAG></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/DataPage" style="color:#000000"><FLAG class="flag_element8"><P class="flag"><FONT color="#FFFFFF">Data Page</FONT></P></FLAG></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Achievements" style="color:#000000"><FLAG class="flag_element9"><P class="flag"><FONT color="#FFFFFF">Achievements</FONT></P></FLAG></A></DIV><UL id="nav"><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec"><FONT color="#FFFFFF">Home</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/ProjectSummary"><FONT color="#FFFFFF">Summary</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/HumanPractice/Synenergene/Applications"><FONT color="#FFFFFF">Applications</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Achievements"><FONT color="#FFFFFF">Achievements</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Bielefueli"><FONT color="#FFFFFF">Bielefueli</FONT></A></LI></UL><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Project/Overview"><FONT color="#FFFFFF">Project</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Project/Overview"><FONT color="#FFFFFF">Overview</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Project/rMFC/Theory"><FONT color="#FFFFFF">rMFC</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Project/CO2-fixation/CarbonDioxide"><FONT color="#FFFFFF">CO<SUB>2</SUB> Fixation</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Project/Isobutanol/Theory"><FONT color="#FFFFFF">Isobutanol</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Project/Biosafety"><FONT color="#FFFFFF">Biosafety</FONT></A></LI><LI><ACTUAL><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Overview"><FONT color="#FFFFFF">Results</FONT></A></ACTUAL></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Team"><FONT color="#FFFFFF">Team</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Team/Members"><FONT color="#FFFFFF">Members</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Team/Subteams"><FONT color="#FFFFFF">Subteams</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/PicturesAndVideos"><FONT color="#FFFFFF">Pictures &amp; Videos</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/BielefeldAndUniversity"><FONT color="#FFFFFF">Bielefeld &amp; University</FONT></A></LI><LI><A href="https://igem.org/Team.cgi?year=2014"><FONT color="#FFFFFF">Official Team Profile</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Acknowledgements"><FONT color="#FFFFFF">Acknowledgements</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Contact"><FONT color="#FFFFFF">Contact</FONT></A></LI><LI style="width:155px;"><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/HumanPractice"><FONT color="#FFFFFF">Policy &amp; Practices</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/HumanPractice/Experts"><FONT color="#FFFFFF">Experts</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/HumanPractice/RadioInterview"><FONT color="#FFFFFF">Interviews</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/HumanPractice/NRW-day"><FONT color="#FFFFFF">NRW-Day</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/HumanPractice/ScholarAcademy"><FONT color="#FFFFFF">Pupils Acedemy</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/HumanPractice/Wikisession"><FONT color="#FFFFFF">How To Wiki</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/HumanPractice/Namu"><FONT color="#FFFFFF">namu</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/HumanPractice/Synenergene"><FONT color="#FFFFFF">SYNENERGENE</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/HumanPractice/Synenergene/Applications"><FONT color="#FFFFFF">Applications</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/HumanPractice/Synenergene/TechnomoralScenario"><FONT color="#FFFFFF">Vignettes</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook"><FONT color="#FFFFFF">Notebook</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Journal"><FONT color="#FFFFFF">Journal</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Protocols"><FONT color="#FFFFFF">Protocols</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Media"><FONT color="#FFFFFF">Media</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/KitsAndEnzymes"><FONT color="#FFFFFF">Kits &amp; Enzymes</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/StrainsAndConstructs"><FONT color="#FFFFFF">Strains &amp; Constructs</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Primer"><FONT color="#FFFFFF">Primer</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Acrynom"><FONT color="#FFFFFF">Acronyms</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Organisms"><FONT color="#FFFFFF">Organisms</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Safety"><FONT color="#FFFFFF">Additional</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Partners"><FONT color="#FFFFFF">Partners</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Partners/GoldSponsor"><FONT color="#FFFFFF">Gold Sponsors</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Partners/SilverSponsor"><FONT color="#FFFFFF">Silver Sponsors</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Partners/BronzeSponsor"><FONT color="#FFFFFF">Bronze Sponsors</FONT></A></LI><LI><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Partners/Partners"><FONT color="#FFFFFF">Partners</FONT></A></LI><H1>Biosafety - Antibiotic-free Selection</H1><DIV id="main_menue" style="margin-left:65px; height:80px"><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosafety" style="color:#000000"><DIV class="main_menueButton"><P class="buttoncenter"><FONT color="#FFFFFF">Motivation</FONT></P></DIV></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosafety/TransformationEfficiency" style="color:#000000"><DIV class="main_menueButton" style="width:230px"><P class="buttoncenter"><FONT color="#FFFFFF">Transformation efficiency</FONT></P></DIV></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosfety/TransformationProcess" style="color:#000000"><DIV class="main_menueButton" style="width:200px"><P class="buttoncenter"><FONT color="#FFFFFF">Transformation process</FONT></P></DIV></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosafety/Long-termStability" style="color:#000000"><DIV class="main_menueButton" style="width:90px"><P class="buttoncenter"><FONT color="#FFFFFF">Stability</FONT></P></DIV></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosafety/Challenges" style="color:#000000"><DIV class="main_menueButton" style="width:100px"><P class="buttoncenter"><FONT color="#FFFFFF">Challenges</FONT></P></DIV></A><A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook" style="color:#000000"><DIV class="main_menueButtonActual" style="width:100px"><P class="buttoncenter"><FONT color="#FFFFFF">Outlook</FONT></P></DIV></A></DIV><DIV class="element" style="margin:10px 10px 10px 10px; padding:10px 10px 10px 10px"><DIV id="text"><H6>Summary</H6><P>
It could be demonstrated, that the antibiotic-free selection system by the D-alanine auxotrophic strain DH5α<I>Δalr</I><I>ΔdadX</I> is not only possible, but even <A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosafety/TransformationEfficiency">more efficent</A> according to the transformation efficiency with the plasmid <A href="http://parts.igem.org/Part:BBa_K1465401">BBa_K1465401</A> then classical approaches. In addition the novel system enables a <A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosfety/TransformationProcess">shorter incubation</A> in SOC media after the transformation to reach comparable transformation efficencies to chloramphenicol. It was demonstrated that this system can be used for molecular cloning of plasmids with normal size like <A href="http://parts.igem.org/Part:BBa_K1465401">BBa_I13522</A> with a total size of 4100 bp. Furthermore the selection via the complementation of the alanine racemase is suitable for  <A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosafety/Long-termStability">long-term</A> cultivations and guarantees a plasmid stability comparable to the antibiotic system with chloramphenicol.
</P><DIV class="element" style="width:600px"><FONT size="2" style=""><B>Figure 12:</B> Comparision of the transformation efficiency for the classical selection with Chloramphenicol (left) or antibiotic-free on normal LB-media (right).</FONT></DIV>

Nevertheless there are remaining challenges for the future to optimize the system of an antibiotic-free selection system. A problematic issue are revertants, which occur in a two times higher ratio of 2.8 % in comparision to the selection with antibiotics (1.5 %). This seems not to be problematic due to the higher transformation efficiency. This might be problematic when none or very few positive colonies are formed, for example in case of difficult transformations with large plasmids. In this case the ratio of false-positive transformants might be higher, which might require the addition of L-methionine or the deletion of <I>metC</I> to obtain an effective selection (<A href="#Kang2011">Kang <I>et al.</I>, 2011</A>).

Another aspect which has to be mentioned is that the plasmid <A href="http://parts.igem.org/Part:BBa_K1465401">BBa_K1465401</A> which is used for the charaterization of the antibiotic-free selection, still contains the coding sequence for the chloramphenicol-resistance. Until now the system is not completely detached from an antibiotic-selection, but the deletion primers for the chloramphenicol resistance gene of the pSB1C3 were already designed and can be found <A href="https://2014.igem.org/Team:Bielefeld-CeBiTec/Notebook/Primer#pSB1C3_Cm_del_fwd" target="_blank">here</A>.
Since the selection via complementation of the alanine racemase has been proven to be functional, there is no longer a hurdle to establish the first overall antibiotic-free selection system in <I>E. coli</I>!

Above all mentioned results this sysem might be not only limited to <I>E. coli</I>. A D-alanine auxotrophy could be already demonstrated for other bacteria like <I>Listeria monocytes</I> (<A href="#Thompson1998">Thompson <I>et al.</I>, 1998</A>),   <I>Corynebacterium glutamicum</I> (<A href="#Tauch2002">Tauch <I>et al.</I>, 2002</A>) or <I>Bacillus subtilis</I> (<A href="#Ferrari1985">Ferrari <I>et al.</I>, 1985</A>). A selection system with complementation of the alanin racemase might be feasible for all bacteria where D-alanine is responsible for the cross-linkage of the peptidoglycane layer.
       </DIV></DIV><DIV class="element" style="margin:10px 10px 10px 10px; padding:10px 10px 10px 10px"><DIV id="text"><H6>References</H6><P><UL><LI id="Ferrari1985"><DIV class="element" style="margin:10px 10px 10px 10px; padding:10px 10px 10px 10px"><DIV id="text">
      E. Ferrari, D. Henner und M. Yang (1985) Isolation of an alanine racemase gene from Bacillus subtilis and its use for plasmid maintenance in B.subtilis. <A href="http://www.nature.com/nbt/journal/v3/n11/pdf/nbt1185-1003.pdf" target="_blank"><I>Nature Biotechnology</I></A>, vol. 3, pp. 1003 - 1007.
  </DIV></DIV></LI><LI id="Kang2011"><DIV class="element" style="margin:10px 10px 10px 10px; padding:10px 10px 10px 10px"><DIV id="text">
      Kang L, Shaw AC, Xu D, Xia W, Zhang J, Deng J, Wöldike HF, Liu Y, Su J. (2011) Upregulation of MetC is essential for D-alanine-independent growth of an alr/dadX-deficient Escherichia coli strain. <A href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067588/pdf/1027-10.pdf" target="_blank"><I>Journal of bacteriology</I></A>, vol. 193, pp. 1098 - 1106.
  </DIV></DIV></LI><LI id="Tauch2002"><DIV class="element" style="margin:10px 10px 10px 10px; padding:10px 10px 10px 10px"><DIV id="text">
      A. Tauch, S. Götker, A. Pühler, J. Kalinowski, G. Thierbach (2002) The alanine racemase gene alr is an alternative to antibiotic resistance genes in cloning systems for industrial Corynebacterium glutamicum strains. <A href="http://ac.els-cdn.com/S0168165602001591/1-s2.0-S0168165602001591-main.pdf?_tid=770bd5ec-5570-11e4-9bc2-00000aacb361&amp;acdnat=1413490405_6fec2c2bbb598b23bfd24b64748541b7" target="_blank"><I> Journal of Biotechnology</I></A>, vol. 99, pp. 79 - 91.
  </DIV></DIV></LI><LI id="Thompson1998"><DIV class="element" style="margin:10px 10px 10px 10px; padding:10px 10px 10px 10px"><DIV id="text">
      R. Thompson, H. Bouwer, D. Portnoy, F. Frankel (1998) Pathogenicity and and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth. <A href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC108386/pdf/ii003552.pdf" target="_blank"><I> Infection and Immunity</I></A>, vol. 66, pp. 3552 - 3561.
  </DIV></DIV></LI></UL></P></DIV></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook">http://2014.igem.org/Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Bielefeld-CeBiTec/Results/Biosafety/Outlook&amp;oldid=380525" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></BODY></HTML>